Over 20 years experience in biotech, leading teams. Team leader at Gendaq, CSO/CEO at Isogenica. Consultant in molecular evolution, peptide, antibody discovery and delivery technologies.
18 years of experience researching oncolytic viruses and has held roles of increasing seniority in academia. Ex-Head of Molecular Virology at PsiOxus, a leading oncolytic virus company.
Head of BD and Strategic Alliances in Therapeutics at Deep Science Ventures, ex Associate Director of Cancer Research UK’s Commercial Partnerships team. Extensive experience in oncology deal-making, including transacting licences, collaboration and spin-outs.
We use cookies to analyze website traffic and optimize your website experience and not for advertising. By accepting our use of cookies, your data will be aggregated with all other user data. We value transparency and a link to our privacy policy can be found on our Contact Us page.